Cellular and molecular pathophysiology of cutaneous drug reactions

被引:106
作者
Pichler W.J. [1 ]
Yawalkar N. [2 ]
Britschgi M. [1 ]
Depta J. [1 ]
Strasser I. [1 ]
Schmid S. [1 ]
Kuechler P. [1 ]
Naisbitt D. [1 ]
机构
[1] Division of Allergology, Inselspital, University of Bern, Bern
[2] Harvard Skin Disease Research Center, Boston, MA
基金
瑞士国家科学基金会;
关键词
Major Histocompatibility Complex; Major Histocompatibility Complex Class; Sulfamethoxazole; Toxic Epidermal Necrolysis; Major Histocompatibility Complex Molecule;
D O I
10.2165/00128071-200203040-00001
中图分类号
学科分类号
摘要
Hypersensitivity reactions to drugs can cause a variety of skin diseases like maculopapular, bullous and pustular eruptions. In recent years increasing evidence indicates the important role of T cells in these drug-induced skin diseases. Analysis of such drug-specific T cell clones has revealed that drugs can be recognized by αβ-T cell receptors, not only if bound covalently to peptides, but also if the drug binds in a rather labile way to the presenting major histocompatibility complex (MHC)-peptide. This presentation is sufficient to stimulate T cells. In maculopapular exanthema (MPE), histopathological analysis typically shows a dominant T cell infiltration together with a vacuolar interface dermatitis. Immunohistochemical studies demonstrate the presence of cytotoxic CD4+ and to a lesser degree of CD8+ T cells, which contain perforin and granzyme B. They are close to keratinocytes that show signs of cell destruction. Expression of Fas ligand is barely detectable, suggesting that cytotoxic granule exocytosis may be the dominant pathway leading to keratinocyte cell damage. While in MPE, the killing of cells seems to be predominately mediated by CD4+ T cells, patients with bullous skin disease show a strong CD8+ T cell migration to the epidermis. This is probably due to a preferential presentation of the drug by MHC class I molecules, and a more extensive killing of cells that present drugs on MHC class 1 molecules. This might lead to bullous skin diseases. In addition to the presence of cytotoxic T cells, drug-specific T cells also orchestrate the inflammatory skin reaction through the release and induction of various cytokines [i.e. interleukin (IL)-5, IL-6, tumor necrosis factor-α and interferon-γ] and chemokines (RANTES, eotaxin or IL-8). The increased expression of these mediators seems to contribute to the generation of tissue and blood eosinophilia, a hallmark of many drug-induced allergic reactions. However, in acute generalized exanthematous pustulosis (a peculiar form of drug allergy), neutrophils represent the predominant cell type within pustules, probably due to their recruitment by IL-8 secreting drug specific T cells and keratinocytes.
引用
收藏
页码:229 / 238
页数:9
相关论文
共 66 条
  • [1] Hunziker T., Kunzi U.P., Braunschweig S., Et al., Comprehensive hospital drug monitoring (CHDM): Adverse skin reactions, a 20-year survey, Allergy, 52, pp. 388-393, (1997)
  • [2] Pichler W.J., Schnyder B., Zanni M., Et al., Role of T cells in drug allergies, Allergy, 53, pp. 225-232, (1998)
  • [3] Hero M., Merk H.F., Lymphocyte activation in cutaneous drug reactions, J Invest Dermatol, 105, pp. 95-98, (1995)
  • [4] Hari Y., Frutig K., Hurni M., Et al., T cell involvement in cutaneous drug eruptions, Clin Exp Allergy, 31, pp. 1398-1403, (2001)
  • [5] Britschgi M., Steiner U., Schmid S., Et al., T cell involvement in drug-induced acute generalized exanthematous pustulosis, J Clin Invest, 107, pp. 1433-1441, (2001)
  • [6] Zanni M.P., Mauri-Hellweg D., Brander C., Et al., Characterization of lidocaine-specific T cells, J Immunol, 158, pp. 1139-1148, (1997)
  • [7] Schnyder B., Mauri-Hellweg D., Zanni M., Et al., Direct, MHC-dependent presentation of the drug sulfamethoxazole to human T cell clones, J Clin Invest, 100, pp. 136-141, (1997)
  • [8] Zanni M.P., Von Greyerz S., Schnyder B., Et al., HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human αaβb T lymphocytes, J Clin Invest, 102, pp. 1591-1598, (1998)
  • [9] Schnyder B., Frutig K., Mauri-Hellweg D., Et al., T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction, Clin Exp Allergy, 28, pp. 1412-1417, (1998)
  • [10] Yawalkar N., Egli F., Hari Y., Et al., Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions, Clin Exp Allergy, 30, pp. 847-855, (2000)